Sectors
Mark Mallery headshot.

Mark A. Mallery

Partner

Mark Mallery is a partner and business lawyer who advises founders, management teams, and private capital investors to navigate growth, manage risk, and achieve their strategic goals. He takes emerging companies from “garage to global,” handling entity structuring, general corporate and equity matters, and day-to-day legal needs. He guides clients through venture and growth financings at every stage, as well as mergers, acquisitions, and restructurings, including transactions valued at up to $1 billion.

Regularly representing clients on either side of financing and acquisition transactions, Mark helps clients anticipate what lies ahead, including preparing companies from day one for future rounds and an eventual exit. He approaches legal counsel with an operator’s perspective, applying his market experience to advance clients’ objectives. Mark also leverages Foley’s extensive platform to provide integrated counsel. 

Mark previously practiced in Silicon Valley and Austin, Texas. Before becoming a lawyer, he was director of operations at StartX, the business accelerator for Stanford entrepreneurs, and a staff researcher at the U.C. Berkeley Transportation Sustainability Research Center.

Mark is a member of Foley’s Private Equity & Venture Capital, M&A, and Transactions Practice Groups, as well as its Private Capital, Innovative Technology, and Health Care & Life Sciences Sectors.

September 29, 2026 Deals and Wins

Foley Represents Pilgrim in Seed Financing

Foley & Lardner LLP represented Pilgrim, a biodefense technology company developing next-generation airborne biosurveillance systems, in its seed financing led by Buckley Ventures.
April 10, 2026 Deals and Wins

Foley Advises Valencia Technologies in Acquisition by Boston Scientific

Foley & Lardner LLP served as legal advisor to Valencia Technologies Corporation, a privately held medical technology company focused on developing and commercializing innovative solutions to treat bladder dysfunction, in its acquisition by global medical technology leader Boston Scientific Corporation.
February 2, 2026 Press Releases

Foley Names 18 New Partners

Foley & Lardner LLP promoted 18 lawyers to the firm’s equity partnership, effective February 1, 2026.
January 15, 2026 Deals and Wins

Foley Advises Rivet Health in Acquisition by Zelis

Foley & Lardner LLP served as legal advisor to Rivet Health Inc., a leader in revenue cycle analytics, in its acquisition by leading health care technology solutions provider Zelis.
December 18, 2025 Deals and Wins

Foley Represents 401GO in $33M Series B Financing

Foley & Lardner LLP represented 401GO, a fully-owned 401(k)-management platform, in its $33 million Series B funding round led by Centana Growth Partners. Additional investors include Next Frontier Capital, Rally Ventures, and Impression Ventures.
July 24, 2025 Deals and Wins

Foley Represents HeroDevs in $125M Strategic Growth Investment from PSG

Foley & Lardner LLP represented HeroDevs, a provider of security and compliance solutions for deprecated open-source software, in securing a $125 million strategic growth investment from PSG, a growth equity firm focused on software and technology-enabled services companies. Existing investor Album also participated in the round.